Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,419.94
(
-0.07%
)
News Focus
News Focus
Post# of 822832
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

brazen22

Send PM Follow Ignore
Followers 2
Posts 203
Boards Moderated 0
Alias Born 09/09/2022

brazen22

Re: HappyLibrarian post# 627662

Saturday, 09/02/2023 12:30:43 PM

Saturday, September 02, 2023 12:30:43 PM

Post# of 822832
The median overall survival for patients with newly diagnosed glioblastoma receiving DCVax-L was 19.3 months. For patients with recurrent glioblastoma, the median overall survival after receiving DCVax-L was 13.2 months, So I don't think waiting for patients to die casued the trial to take so long
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News